Lola Fashoyin-Aje

31PUBLICATIONS
156CO-AUTHORS
Liquid biopsiesMolecular medicineAvionicsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Jul 23, 2025
FDA Approval Summary: Lifileucel for Unresectable or Metastatic Melanoma Previously Treated with an Anti-PD-1-Based Immunotherapy.

Lianne Hu, Chaohong Fan, Peter Bross

|Jul 15, 2025
FDA Approval Summary: Lisocabtagene Maraleucel for Relapsed or Refractory Follicular Lymphoma.

Kristen Britton, Upendra Mahat, Nicholas C Richardson

|Jun 04, 2025
FDA Approval Summary: Idecabtagene Vicleucel for the Treatment of Triple-Class-Exposed, Relapsed or Refractory Multiple Myeloma.

Poornima Sharma, Xue Lin, Zhenzhen Xu

|May 27, 2025
FDA Approval Summary: Afamitresgene Autoleucel for Adults with HLA-Restricted, MAGE-A4-Positive Unresectable or Metastatic Synovial Sarcoma after Prior Chemotherapy.

Katherine K Barnett, Abigail R Johnson, Asha Das

|May 04, 2025
FDA Experience on CAR T Cell Pharmacokinetics/Pharmacodynamics and Model-Based Assessments.

Million A Tegenge, Xiaofei Wang, Jiang Liu

|Dec 20, 2024
FDA Approval Summary: Nadofaragene Firadenovec-vncg for Bacillus Calmette-Guérin-Unresponsive Non-Muscle-Invasive Bladder Cancer.

Laronna Colbert, Yuxia Jia, Anurag Sharma

Pageof 6

Frequent Collaborators

11 joint publications

Richard Pazdur

9 joint publications

Steven J Lemery

9 joint publications

Paul G Kluetz

6 joint publications

Sandra J Casak